The advanced data analytics provider IBM Watson Health has signed its first big pharma partner, Pfizer Inc., for a new computational tool called Watson for Drug Discovery. Pfizer will use Watson’s new cloud-based data analytics tool to discover new drugs faster in the area of immuno-oncology, with a focus on discovery of new and unexplored drug targets, potential combination therapies and patient selection strategies.
The companies announced the collaboration Dec
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?